Simplex Trading’s Audentes Therapeutics, Inc BOLD Stock Holding History

Simplex Trading’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-470	Closed	-$28K	–	8715
2019 Q4	$28K	Sell	470 -2,130	-82%	-$79.9K	﹤0.01%	5722
2019 Q3	$73K	Sell	2,600 -3,042	-54%	-$104K	﹤0.01%	4669
2019 Q2	$213K	Buy	+5,642	New	+$217K	﹤0.01%	3411
2019 Q1	–	Sell	-1,188	Closed	-$34.1K	–	8265
2018 Q4	$25K	Sell	1,188 -1,059	-47%	-$27.3K	﹤0.01%	5181
2018 Q3	$88K	Buy	+2,247	New	+$83.8K	﹤0.01%	4572
2018 Q2	–	Sell	-791	Closed	-$23K	–	8178
2018 Q1	$23K	Buy	+791	New	+$26.8K	﹤0.01%	3236

Simplex Trading's BOLD Position: Q1 2020 in Review

Simplex Trading sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 470 shares — an estimated $28K sold.

Simplex Trading first reported a position in BOLD in Q1 2018 and held it in 6 quarters. The position peaked at $213K in Q2 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Simplex Trading reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Simplex Trading sold 470 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $28K.
Simplex Trading first reported a position in Audentes Therapeutics, Inc in Q1 2018 and held it in 6 quarters.
Simplex Trading's Audentes Therapeutics, Inc position peaked at $213K in Q2 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Simplex Trading's 13F filing for Q1 2020, filed 29 Apr 2020.